Scilex Holding Co

Scilex Holding Company, trading under ticker VCKA on Nasdaq, is the post-combination entity formed through the merger of Vickers Vantage Corp. I and Scilex Pharmaceuticals, a specialty pharmaceutical company focused on non-opioid pain management treatments. Vickers Vantage Corp. I, sponsored by Vickers Venture Fund, completed its SPAC IPO in 2021 within the healthcare sector. The company filed an 8-K current report with the SEC on May 5, 2023, accession number 0001193125-23-137199, reflecting a material disclosure event following the close of the business combination. Scilex operates in the specialty pharmaceuticals space, developing and commercializing products targeting acute and chronic pain conditions. Sign up at SpacDesk for full filing history, sponsor data, and real-time SPAC analytics on VCKA and hundreds of other vehicles.